Herold, Z.; Herold, M.; Szentmartoni, G.; Szalasy, R.; Lohinszky, J.; Somogyi, A.; Szasz, A.M.; Dank, M.
Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study. Med. Sci. 2025, 13, 108.
https://doi.org/10.3390/medsci13030108
AMA Style
Herold Z, Herold M, Szentmartoni G, Szalasy R, Lohinszky J, Somogyi A, Szasz AM, Dank M.
Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study. Medical Sciences. 2025; 13(3):108.
https://doi.org/10.3390/medsci13030108
Chicago/Turabian Style
Herold, Zoltan, Magdolna Herold, Gyongyver Szentmartoni, Reka Szalasy, Julia Lohinszky, Aniko Somogyi, Attila Marcell Szasz, and Magdolna Dank.
2025. "Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study" Medical Sciences 13, no. 3: 108.
https://doi.org/10.3390/medsci13030108
APA Style
Herold, Z., Herold, M., Szentmartoni, G., Szalasy, R., Lohinszky, J., Somogyi, A., Szasz, A. M., & Dank, M.
(2025). Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study. Medical Sciences, 13(3), 108.
https://doi.org/10.3390/medsci13030108
